Hypoxia-induced increase in FDG uptake in MCF7 cells Journal Article


Authors: Burgman, P.; O'Donoghue, J. A.; Humm, J. L.; Ling, C. C.
Article Title: Hypoxia-induced increase in FDG uptake in MCF7 cells
Abstract: Recent clinical data indicate that tumor hypoxia negatively affects the treatment outcome of both radiotherapy and surgery in various cancers, emphasizing the need for noninvasive detection of tumor hypoxia. Several studies have shown an increased uptake of FDG in hypoxic regions of xenografts, suggesting the use of PET with FDG as a potential technique. In this study, we examine the mechanism underlying the hypoxia-induced increase of FDG uptake in the human breast carcinoma cell line MCF7. Methods: The uptake of 3H-FDG into MCF7 cells was determined after incubation under hypoxic (0% oxygen) or normoxic conditions, with or without redox agents, for varying time periods. In addition, the effects of the redox agents on the glucose transporter activity and the hexokinase activity were determined independently, and the effects of hypoxia on glucose transporter protein and hexokinase levels were assessed. Results: A more than twofold increase (2.53 ± 0.79; P < 0.005) in 3H-FDG uptake was observed under hypoxic conditions, but no changes in the cellular levels of glucose transporter proteins or hexokinase were observed. A reducing agent, dithiothreitol (DTT), also caused an increase in 3H-FDG uptake but failed to affect uptake under hypoxic conditions. This indicates that the mechanisms by which hypoxia and DTT affect 3H-FDG uptake might be the same. The oxidizing agent p-chloromercuribenzenesulfonic acid (pCMBS) had no effect on 3H-FDG uptake under normoxic conditions but counteracted the effect of hypoxia. DTT caused an increase in glucose transporter activity, whereas it had no effect on hexokinase activity. pCMBS had no effect on either glucose transporter activity or hexokinase activity. Conclusion: The hypoxia-induced increase in 3H-FDG uptake in MCF7 cells is the result, in part, of an increase in glucose transporter activity resulting from the modification (reduction) of thiol group(s) in the glucose transport protein(s). Modulation of hexokinase activity is probably not involved in the hypoxia-induced increase in 3H-FDG uptake in these cells.
Keywords: controlled study; treatment outcome; human cell; cancer radiotherapy; positron emission tomography; cell line; tumor cells, cultured; enzyme activity; breast neoplasms; drug uptake; xenograft; fluorodeoxyglucose f18; cell hypoxia; pet; cell strain mcf 7; fluorodeoxyglucose; oxidation reduction reaction; fdg; tritium; glucose transporter; hexokinase; thiol; monosaccharide transport proteins; dithiothreitol; humans; human; female; priority journal; article; phypoxia; protein thiols; redox modification of; chloromercuribenzenesulfonic acid; 4-chloromercuribenzenesulfonate
Journal Title: Journal of Nuclear Medicine
Volume: 42
Issue: 1
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2001-01-01
Start Page: 170
End Page: 175
Language: English
PUBMED: 11197971
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Citation Impact
MSK Authors
  1. John Laurence Humm
    433 Humm
  2. Paul Burgman
    18 Burgman
  3. C Clifton Ling
    331 Ling